|
Market Closed -
NYSE
16:00:00 2026-08-21 EDT
|
5-day change | 1st Jan Change | ||
| 1.420 USD | -2.74% |
|
-7.79% | -73.00% |
| Market Cap | 24.82M 21.26M 19.89M 18.21M 34.17M 2.37B 34.62M 235M 91.65M 1.19B 93.19M 91.16M 3.95B | P/E 2026 * |
-0.46x | P/E 2027 * | -0.22x |
|---|---|---|---|---|---|
| Enterprise Value | 19.26M 16.5M 15.44M 14.13M 26.52M 1.84B 26.87M 182M 71.14M 926M 72.33M 70.76M 3.06B | EV / Sales 2026 * |
-
| EV / Sales 2027 * | 3.26x |
| Free-Float |
93.73% | Yield 2026 * |
-
| Yield 2027 * | - |
| 23-07-18 | Wall Street sluit hoger | |
| 23-07-18 | Wall Street op winst | |
| 23-07-18 | Wall Street richting licht rode opening | |
| 23-07-18 | Futures voorspellen terughoudende opening Wall Street | |
| 21-06-28 | Cel-Sci presenteert positieve onderzoeksdata immunotherapie |
| 1 day | -2.74% | ||
| 1 week | -7.79% | ||
| Current month | +22.41% | ||
| 1 month | +15.45% | ||
| 6 months | -70.42% | ||
| Current year | -73.00% |
| 1 week | 1.42 |  | 1.69 |
| 1 month | 1.14 | | 1.75 |
| Current year | 0.89 | | 6.75 |
| 1 year | 0.89 | | 13.48 |
| 3 years | 0.89 | | 96.91 |
| 5 years | 0.89 | | 387.04 |
| 10 years | 0.89 | | 1,227.42 |
| Manager | Title | Age | Since |
|---|---|---|---|
Geert Kersten
CEO | Chief Executive Officer | 67 | 1994-12-31 |
Patricia Prichep
DFI | Director of Finance/CFO | 75 | 2024-11-12 |
| Chief Tech/Sci/R&D Officer | - | 2024-04-30 |
| Director | Title | Age | Since |
|---|---|---|---|
Geert Kersten
BRD | Director/Board Member | 67 | 1994-12-31 |
| Director/Board Member | 73 | 2015-06-21 | |
Bob Watson
CHM | Chairman | 69 | 2024-07-07 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 8/14/26 | Free | Chief Financial Officer | 225,000 | 1.2874% | ||
| 8/14/26 | Free | Director | 110,000 | 0.6294% | ||
| 8/14/26 | Free | General Counsel | 80,000 | 0.4577% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -2.74% | -7.79% | -85.08% | -96.60% | 24.82M | |
| -3.00% | +2.27% | +73.26% | +109.90% | 72.12B | |
| +1.90% | +23.53% | +59.48% | +94.82% | 65.85B | |
| +5.12% | +25.22% | +5.13% | -5.86% | 29.28B | |
| +0.55% | +1.64% | -4.63% | +480.92% | 27.47B | |
| +2.74% | +12.98% | +54.92% | +25.77% | 26.7B | |
| +0.47% | +6.12% | +37.01% | -15.31% | 20.06B | |
| +1.82% | -6.67% | +251.36% | +388.91% | 18.22B | |
| +0.94% | +3.36% | +15.30% | +548.19% | 16.4B | |
| +0.73% | +5.54% | +39.99% | +151.77% | 13.4B | |
| Average | +0.85% | +6.75% | +44.67% | +168.25% | 28.95B | |
| Weighted average by Cap. | +0.74% | +9.48% | +58.01% | +157.84% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | - | 5.97M 5.12M 4.79M 4.38M 8.22M 571M 8.33M 56.55M 22.05M 287M 22.42M 21.94M 949M |
| Net income | -25.08M -21.49M -20.1M -18.4M -34.54M -2.4B -34.99M -238M -92.63M -1.21B -94.19M -92.14M -3.99B | -29.51M -25.28M -23.66M -21.65M -40.64M -2.82B -41.17M -279M -109M -1.42B -111M -108M -4.69B |
| Net Debt | -5.55M -4.76M -4.45M -4.07M -7.65M -531M -7.75M -52.59M -20.51M -267M -20.85M -20.4M -883M | -5.34M -4.57M -4.28M -3.92M -7.35M -511M -7.45M -50.56M -19.72M -257M -20.05M -19.61M -849M |
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-08-21 | US$1.420 | -2.74% | 66,143 |
| 26-08-20 | US$1.460 | -10.98% | 183,495 |
| 26-08-19 | US$1.640 | +3.14% | 184,790 |
| 26-08-18 | US$1.590 | +2.58% | 228,788 |
| 26-08-17 | US$1.550 | +0.65% | 129,424 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Annual profits - Rate of surprise
- Stock Market
- Stocks
- CVM Stock
Select your edition
All financial news and data tailored to specific country editions
